{"id":959,"date":"2021-04-08T15:34:00","date_gmt":"2021-04-08T15:34:00","guid":{"rendered":"https:\/\/www.ub.edu\/creatio\/wp\/?post_type=actualitat&#038;p=959"},"modified":"2022-10-05T07:29:10","modified_gmt":"2022-10-05T07:29:10","slug":"sc4hd-4","status":"publish","type":"actualitat","link":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/","title":{"rendered":"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades)"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" data-src=\"https:\/\/www.ub.edu\/creatio\/wp\/wp-content\/uploads\/2022\/08\/SC4HD-Consorci-Internacional_Terapies-Avancades-edited.jpg\" alt=\"Stem Cells for Huntington\u2019s Disease\" class=\"wp-image-962 lazyload\" width=\"307\" height=\"205\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" style=\"--smush-placeholder-width: 307px; --smush-placeholder-aspect-ratio: 307\/205;\" \/><noscript><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.ub.edu\/creatio\/wp\/wp-content\/uploads\/2022\/08\/SC4HD-Consorci-Internacional_Terapies-Avancades-edited.jpg\" alt=\"Stem Cells for Huntington\u2019s Disease\" class=\"wp-image-962\" width=\"307\" height=\"205\"\/><\/noscript><\/figure><\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>The Stem Cells for Huntington\u2019s Disease (<\/strong><a href=\"https:\/\/www.sc4hd.org\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>SC4HD<\/strong><\/a><strong>) \u00e9s un nou consorci internacional creat per impulsar medicaments de ter\u00e0pia avan\u00e7ada (ATMP), mitjan\u00e7ant el trasplantament de c\u00e8l\u00b7lules mare, per tractar la malaltia de Huntington. L\u2019entitat, formada per vint-i-vuit investigadors de renom de deu pa\u00efsos, s\u2019ha presentat oficialment a la revista&nbsp;<em>Journal of Huntington\u2019s Disease<\/em>.<\/strong><\/h3>\n\n\n\n<p>Els objectius principals del consorci SC4HD s\u00f3n treballar conjuntament amb la comunitat afectada per la malaltia de Huntington per desenvolupar criteris i guies, i abordar els principals reptes per implementar d\u2019una manera r\u00e0pida i segura les ter\u00e0pies basades en c\u00e8l\u00b7lules mare als pacients amb aquesta patologia devastadora.<\/p>\n\n\n\n<p>Segons explica Josep M. Canals, director de Creatio i membre del Comit\u00e8 Directiu de SC4HD, \u00ables ter\u00e0pies basades en c\u00e8l\u00b7lules mare s\u00f3n una gran oportunitat per tractar la malaltia de Huntington, un trastorn neurodegeneratiu que afecta principalment les neurones del nucli estriat del cervell\u00bb.<\/p>\n\n\n\n<p>Fins ara, moltes ter\u00e0pies cel\u00b7lulars experimentals s\u2019han centrat en el nucli estriat amb la finalitat de substituir les neurones que s\u2019han perdut durant el proc\u00e9s de la malaltia. D\u2019aquesta manera, es pret\u00e9n reparar el circuit neuronal o augmentar la superviv\u00e8ncia de les neurones restants i de les c\u00e8l\u00b7lules neuronals i glials del nucli estriat. Els aven\u00e7os tecnol\u00f2gics dirigits a la diferenciaci\u00f3 de les c\u00e8l\u00b7lules mare cap als tipus neuronals desitjats obren noves estrat\u00e8gies per restaurar els circuits neuronals danyats en la malaltia de Huntington.<\/p>\n\n\n\n<p>El consorci SC4HD reuneix experts en biologia de c\u00e8l\u00b7lules mare, trasplantament de c\u00e8l\u00b7lules, producci\u00f3 de c\u00e8l\u00b7lules de grau cl\u00ednic, neurocirurgia i avaluaci\u00f3 cl\u00ednica per a una aplicaci\u00f3 cl\u00ednica segura de les ter\u00e0pies amb c\u00e8l\u00b7lules mare, oferint l\u2019estandarditzaci\u00f3 de protocols i guies completes que engloben tot el ventall de consideracions terap\u00e8utiques.<br>&nbsp;<\/p>\n\n\n\n<p><strong>Participaci\u00f3 de la Universitat de Barcelona<\/strong><\/p>\n\n\n\n<p>Josep M. Canals \u00e9s professor del Departament de Biomedicina de la Facultat de Medicina i Ci\u00e8ncies de la Salut de la UB i director del Centre per a la Producci\u00f3 i Validaci\u00f3 de Ter\u00e0pies Avan\u00e7ades (<a href=\"https:\/\/www.ub.edu\/creatio\/#!\/home\">Creatio<\/a>), el centre TECNIO per a la producci\u00f3 de medicaments de ter\u00e0pia avan\u00e7ada a Catalunya. Aix\u00ed mateix, dirigeix el Grup de Recerca en C\u00e8l\u00b7lules Mare i Medicina Regenerativa de la UB.<\/p>\n\n\n\n<p>Unai Perpi\u00f1\u00e1, que \u00e9s responsable t\u00e8cnic a Creatio i professor del mateix Departament de Biomedicina, tamb\u00e9 participa en el consorci SC4HD.<\/p>\n\n\n\n<p>Tots dos s\u00f3n membres de l\u2019Institut de Neuroci\u00e8ncies de la UB (<a href=\"http:\/\/www.neurociencies.ub.edu\/\">UBNeuro<\/a>), de l\u2019Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), del Centre d\u2019Investigaci\u00f3 Biom\u00e8dica en Malalties Neurodegeneratives (CIBERNED) i de la Xarxa Espanyola de Ter\u00e0pia Cel\u00b7lular (TerCel).<\/p>\n\n\n\n<p>v\u00eddeo:&nbsp;<a href=\"https:\/\/youtu.be\/8Pb0nkKnXWE\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/youtu.be\/8Pb0nkKnXWE<\/a><\/p>\n\n\n\n<p><br><strong>Refer\u00e8ncia de l\u2019article:<\/strong><\/p>\n\n\n\n<p>Canals, J. M.; Perpi\u00f1\u00e1, U. et al.&nbsp;<a href=\"https:\/\/content.iospress.com\/articles\/journal-of-huntingtons-disease\/jhd210473\" target=\"_blank\" rel=\"noreferrer noopener\">\u00abStem cells for Huntington\u2019s disease (SC4HD): an international consortium to facilitate stem cell-based therapy for Huntington\u2019s disease\u00bb<\/a>.&nbsp;<em>Journal of Huntington\u2019s Disease<\/em>, febrer de 2021. DOI: 10.3233\/JHD-210473.<\/p>\n","protected":false},"author":1,"featured_media":815,"template":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio\" \/>\n<meta property=\"og:description\" content=\"The Stem Cells for Huntington\u2019s Disease (SC4HD) \u00e9s un nou consorci internacional creat per impulsar medicaments de ter\u00e0pia avan\u00e7ada (ATMP), mitjan\u00e7ant el trasplantament de c\u00e8l\u00b7lules mare, per tractar la malaltia de Huntington. L\u2019entitat, formada per vint-i-vuit investigadors de renom de deu pa\u00efsos, s\u2019ha presentat oficialment a la revista&nbsp;Journal of Huntington\u2019s Disease. Els objectius principals del [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Creatio\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-05T07:29:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"260\" \/>\n\t<meta property=\"og:image:height\" content=\"174\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Creatio_UB\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/\",\"url\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/\",\"name\":\"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio\",\"isPartOf\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg\",\"datePublished\":\"2021-04-08T15:34:00+00:00\",\"dateModified\":\"2022-10-05T07:29:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage\",\"url\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg\",\"contentUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg\",\"width\":260,\"height\":174,\"caption\":\"Logo del stem Cells for Huntington\u2019s Disease consortium\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.ub.edu\/creatio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#website\",\"url\":\"https:\/\/www.ub.edu\/creatio\/\",\"name\":\"Creatio\",\"description\":\"Production and validation center of advanced therapies\",\"publisher\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ub.edu\/creatio\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#organization\",\"name\":\"Creatio\",\"url\":\"https:\/\/www.ub.edu\/creatio\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png\",\"contentUrl\":\"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png\",\"width\":698,\"height\":110,\"caption\":\"Creatio\"},\"image\":{\"@id\":\"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Creatio_UB\",\"https:\/\/www.linkedin.com\/company\/creatio-ub\",\"https:\/\/www.instagram.com\/creatio.ub\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/","og_locale":"es_ES","og_type":"article","og_title":"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio","og_description":"The Stem Cells for Huntington\u2019s Disease (SC4HD) \u00e9s un nou consorci internacional creat per impulsar medicaments de ter\u00e0pia avan\u00e7ada (ATMP), mitjan\u00e7ant el trasplantament de c\u00e8l\u00b7lules mare, per tractar la malaltia de Huntington. L\u2019entitat, formada per vint-i-vuit investigadors de renom de deu pa\u00efsos, s\u2019ha presentat oficialment a la revista&nbsp;Journal of Huntington\u2019s Disease. Els objectius principals del [&hellip;]","og_url":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/","og_site_name":"Creatio","article_modified_time":"2022-10-05T07:29:10+00:00","og_image":[{"width":260,"height":174,"url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Creatio_UB","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/","url":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/","name":"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades) - Creatio","isPartOf":{"@id":"https:\/\/www.ub.edu\/creatio\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage"},"image":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg","datePublished":"2021-04-08T15:34:00+00:00","dateModified":"2022-10-05T07:29:10+00:00","breadcrumb":{"@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#primaryimage","url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg","contentUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2022\/08\/stem-Cells-for-Huntingtons-Disease-consortium.jpg","width":260,"height":174,"caption":"Logo del stem Cells for Huntington\u2019s Disease consortium"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ub.edu\/creatio\/actualitat\/sc4hd-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ub.edu\/creatio\/"},{"@type":"ListItem","position":2,"name":"SC4HD Consorci Internacional (Ter\u00e0pies Avan\u00e7ades)"}]},{"@type":"WebSite","@id":"https:\/\/www.ub.edu\/creatio\/#website","url":"https:\/\/www.ub.edu\/creatio\/","name":"Creatio","description":"Production and validation center of advanced therapies","publisher":{"@id":"https:\/\/www.ub.edu\/creatio\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ub.edu\/creatio\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ub.edu\/creatio\/#organization","name":"Creatio","url":"https:\/\/www.ub.edu\/creatio\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/","url":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png","contentUrl":"https:\/\/www.ub.edu\/creatio\/wp-content\/uploads\/2021\/12\/creatio-logo.png","width":698,"height":110,"caption":"Creatio"},"image":{"@id":"https:\/\/www.ub.edu\/creatio\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Creatio_UB","https:\/\/www.linkedin.com\/company\/creatio-ub","https:\/\/www.instagram.com\/creatio.ub\/"]}]}},"lang":"ca","translations":{"ca":959,"es":963,"en":966},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/actualitat\/959"}],"collection":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/actualitat"}],"about":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/types\/actualitat"}],"author":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/media\/815"}],"wp:attachment":[{"href":"https:\/\/www.ub.edu\/creatio\/wp-json\/wp\/v2\/media?parent=959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}